First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

Updated on: September 30,2024

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

Updated on:September 30,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on: January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on:January 16,2024

Scrapping England's cancer plan is 'a catastrophic decision that will cost lives' warn experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such a

Updated on: January 22,2024

Scrapping England's cancer plan is 'a catastrophic decision that will cost lives' warn experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such a

Updated on:January 22,2024

Discovery paves way for precision medicine in future

by University of OtagoThis high-dimensional analysis reveals the T cell signature in people with bowel cancer. The new analysis groups cells together so all cells can be viewed at once. In the pa

Updated on: April 18,2024

Discovery paves way for precision medicine in future

by University of OtagoThis high-dimensional analysis reveals the T cell signature in people with bowel cancer. The new analysis groups cells together so all cells can be viewed at once. In the pa

Updated on:April 18,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on: April 07,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on:April 07,2024

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

Updated on: March 06,2024

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

Updated on:March 06,2024

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Updated on: May 17,2024

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Updated on:May 17,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on: January 02,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on:January 02,2024

Study outlines targeted treatment option for aggressive breast cancer

by University of MarylandMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainNew findings put forth by the University of Maryland Fischell Department

Updated on: March 01,2024

Study outlines targeted treatment option for aggressive breast cancer

by University of MarylandMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainNew findings put forth by the University of Maryland Fischell Department

Updated on:March 01,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on: March 12,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on:March 12,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on: February 03,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on:February 03,2024

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)

Updated on: January 30,2024

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)

Updated on:January 30,2024